ImmunityBio, Inc.

NASDAQ:IBRX

5.3 (USD) • At close November 7, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019201820172016201520142013
Assets:
Current Assets:
Cash & Cash Equivalents 265.453104.641181.10134.91515.50816.82123.8728.083175.90859.1040.35
Short Term Investments 1.0092.543136.01561.14636.14457.328104.28190.838118.3100
Cash and Short Term Investments 266.462107.184317.11696.06151.65274.149128.152198.921294.21859.1040.35
Net Receivables 3.1681.891.3332.0030.30312.1681.2582.6681.7740.1450.38
Inventory 026.354000000000
Other Current Assets 24.4545.14915.89813.6493.8022.4553.0483.5561.5480.1240.248
Total Current Assets 294.084140.577334.347111.71355.75788.772132.458205.145297.5459.3730.978
Non-Current Assets:
Property, Plant & Equipment, Net 182.683189.447119.16790.67972.2376.88576.72619.2686.1470.2110.013
Goodwill 00000000000
Intangible Assets 17.09320.0031.421.46312.07412.0852.8265.0867.2920.8350.863
Goodwill and Intangible Assets 17.09320.0031.421.46312.07412.0852.8265.0867.2920.8350.863
Long Term Investments 8.1045.76.77510.44710.92914.3838.27987.7555.13500
Tax Assets 0003.7393.233-8.500.110.39100
Other Non-Current Assets 2.4886.6297.2013.34-11.1-1.6720.1510.1370.3440.4090.249
Total Non-Current Assets 210.368221.779134.563109.66887.36693.178117.982112.35169.3091.4551.125
Total Assets 504.452362.356468.91221.381143.123181.95250.44317.496366.84960.8282.103
Liabilities & Equity:
Current Liabilities:
Account Payables 9.19521.01611.41811.511.7492.7935.8654.0452.0851.1311.501
Short Term Debt 6.783434.551302.2475.0153.9630.9650.6180.534-0.2280.2651.76
Tax Payables 00000000000
Deferred Revenue 0.10.100000.520.1970.2280.5210.573
Other Current Liabilities 42.20545.19455.3351.6095.84723.50213.8657.7774.0630.4881.164
Total Current Liabilities 58.283500.861368.99568.13411.55927.2620.86812.5536.1482.4054.998
Non-Current Liabilities:
Long Term Debt 836.952289.222343.417270.532181.62105.2012.8622.46800
Deferred Revenue Non-Current 000010.88500.1660.1870.22800
Deferred Tax Liabilities Non-Current 000.1620.173.23300.4980.9961.16500
Other Non-Current Liabilities 195.15422.0930.2491.035-184.8548.6844.8637.480.8451.9173.834
Total Non-Current Liabilities 1,032.106311.315343.828271.73710.8858.68410.72811.5254.7061.9173.834
Total Liabilities 1,090.389812.176712.823339.87122.44435.94431.59624.07810.8542.4054.998
Equity:
Preferred Stock 00000000000
Common Stock 0.0670.0420.040.0380.010.0080.0080.0080.0080.0030.002
Retained Earnings -2,961.684-2,378.488-1,961.921-1,615.131-662.191-594.981-498.713-387.063-250.376-12.741-6.528
Accumulated Other Comprehensive Income/Loss 0.010.1830.0040.122-0.105-0.267-0.381-0.284-0.192-0.046-0.009
Other Total Stockholders Equity 2,374.621,930.9361,719.7041,495.163782.965741.246717.93680.757606.55571.2073.64
Total Shareholders Equity -586.987-447.327-242.173-119.808120.679146.006218.844293.418355.99558.423-2.895
Total Equity -585.937-449.82-243.913-118.49124.333133.688218.844293.418355.99558.423-2.895
Total Liabilities & Shareholders Equity 504.452362.356468.91221.381143.123181.95250.44317.496366.84960.8282.103